Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2009 May 15:286–352. doi: 10.1016/B978-0-7216-8676-9.50013-2

Diseases of the Liver and Hepatobiliary System

Keith P Richter
Editor: Todd R Tams1,2
PMCID: PMC7155502

The content is available as a PDF (481.5 KB).

References

  1. Allen L. Clinicopathologic features of dogs with hepatic microvascular dysplasia with and without portosystemic shunts: 42 cases (1991–1996) J Am Vet Med Assoc. 1999;214:218. [PubMed] [Google Scholar]
  2. Aronson LR. Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts. Vet Surg. 1997;26:189. doi: 10.1111/j.1532-950x.1997.tb01483.x. [DOI] [PubMed] [Google Scholar]
  3. Berry W, Reichen J. Bile acid metabolism: its relation to clinical disease. Semin Liver Dis. 1983;3:330. doi: 10.1055/s-2008-1040785. [DOI] [PubMed] [Google Scholar]
  4. Biller DS, Kantrowitz B, Miyabayashi T. Ultrasonography of diffuse liver disease. J Vet Intern Med. 1992;6:71. doi: 10.1111/j.1939-1676.1992.tb03154.x. [DOI] [PubMed] [Google Scholar]
  5. Birchard SJ, Sherding RG. Feline portosystemic shunts. Comp Cont Educ Pract Vet. 1992;14:1295. [Google Scholar]
  6. Boothe HW. Use of hepatobiliary scintigraphy in the diagnosis of extrahepatic biliary obstruction in dogs and cats: 25 cases (1982–1989) J Am Vet Med Assoc. 1992;201:134. [PubMed] [Google Scholar]
  7. Brewer GJ. Use of zinc acetate to treat copper toxicosis in dogs. J Am Vet Med Assoc. 1992;201:564. [PubMed] [Google Scholar]
  8. Breznock EM, Whiting PG. Portacaval shunts and anomalies. In: Slatter DH, editor. vol 1. WB Saunders; Philadelphia: 1985. (Textbook of small animal surgery). [Google Scholar]
  9. Center SA. Feline liver disorders and their management. Comp Cont Educ Pract Vet. 1986;8:889. [Google Scholar]
  10. Center SA, Erb HN, Joseph SA. Measurement of serum bile acids concentrations for diagnosis of hepatobiliary disease in cats. J Am Vet Med Assoc. 1995;207:1048. [PubMed] [Google Scholar]
  11. Center SA, Magne ML. Historical, physical examination, and clinicopathologic features of portosystemic vascular anomalies in the dog and cat. Semin Vet Med Surg. 1990;5:83. [PubMed] [Google Scholar]
  12. Center SA, Slater MR, Manwarren T. Diagnostic efficacy of serum alkaline phosphatase and gamma-glutamyltransferase in dogs with histologically confirmed hepatobiliary disease: 270 cases (1980–1990) J Am Vet Med Assoc. 1992;201:1258. [PubMed] [Google Scholar]
  13. Center SA. Bile acid concentrations in the diagnosis of hepatobiliary disease in the dog. J Am Vet Med Assoc. 1985;187:935. [PubMed] [Google Scholar]
  14. Center SA. Bile acid concentrations in the diagnosis of hepatobiliary disease in the cat. J Am Vet Med Assoc. 1986;189:891. [PubMed] [Google Scholar]
  15. Center SA: Hepatic lipidosis in the cat. Proceedings of the fourth annual Veterinary Medicine Forum, American College of Veterinary Internal Medicine, Washington, DC, 13, 1986.
  16. Center SA: S-adenosylmethionine (SAMe): an antioxidant and anti-inflammatory nutraceutical. Proceedings of the eighteenth American College of Veterinary Internal Medicine Forum; 2000, 550–552.
  17. Center SA: S-adenosylmethionine (SAMe), glutathione (GSH), & Vitamin B12 rescue therapy in cats with hepatic lipidosis. Proceedings of the seventh International Veterinary Emergency and Critical Care Symposium (IVECCS); 2000, 230–235.
  18. Farrar ET, Washabau RJ, Saunders HM. Hepatic abscesses in dogs: 14 cases (1982–1994) J Am Vet Med Assoc. 1996;208:243. [PubMed] [Google Scholar]
  19. Feldman EC, Ettinger SJ. Percutaneous transthoracic liver biopsy in the dog. J Am Vet Med Assoc. 1976;169:805. [PubMed] [Google Scholar]
  20. Fraser CL, Arieff AI. Hepatic encephalopathy. N Engl J Med. 1985;313:865. doi: 10.1056/NEJM198510033131406. [DOI] [PubMed] [Google Scholar]
  21. Gagne JM. Clinical features of inflammatory liver disease in cats: 41 cases (1983–1993) J Am Vet Med Assoc. 1999;214:513. [PubMed] [Google Scholar]
  22. Grooters AM, Sherding RG, Johnson SE. Hepatic abscesses in dogs. Comp Cont Educ Pract Vet. 1995;17:833. [Google Scholar]
  23. Hardie EM, Kornegay JN, Cullen JM. Status epilepticus after ligation of portosystemic shunts. Vet Surg. 1990;19:412. doi: 10.1111/j.1532-950x.1990.tb01224.x. [DOI] [PubMed] [Google Scholar]
  24. Hardy RM. Diseases of the liver. In: Ettinger SJ, editor. Textbook of veterinary internal medicine, vol 2, Diseases of the dog and cat. WB Saunders; Philadelphia: 1983. [Google Scholar]
  25. Hardy RW. Copper-associated hepatitis in Bedlington terriers. In: Kirk RW, editor. Current veterinary therapy VIII. WB Saunders; Philadelphia: 1983. [Google Scholar]
  26. Hardy RW. Hepatic biopsy. In: Kirk RW, editor. Current veterinary therapy VIII. WB Saunders; Philadelphia: 1983. [Google Scholar]
  27. Hardy RW. Chronic hepatitis in dogs: a syndrome. Comp Cont Educ Pract Vet. 1986;8:904. [Google Scholar]
  28. Hunt GB, Bellénger CR, Pearson MRB. Transportal approach for attenuating intrahepatic portosystemic shunts in dogs. Vet Surg. 1996;25:300. doi: 10.1111/j.1532-950x.1996.tb01417.x. [DOI] [PubMed] [Google Scholar]
  29. Jones BD, Hitt M, Hurst T. Hepatic biopsy. Vet Clin North Am. 1985;15:39. doi: 10.1016/s0195-5616(85)50003-0. [DOI] [PubMed] [Google Scholar]
  30. Kershenobich D. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med. 1988;318:1709. doi: 10.1056/NEJM198806303182602. [DOI] [PubMed] [Google Scholar]
  31. Kobilk PD. Use of transcolonic 99mtechnetium-pertechnetate as a screening test for portosystemic shunts in dogs. J Am Vet Med Assoc. 1990;196:925. [PubMed] [Google Scholar]
  32. Komtebedde J. Long-term clinical outcome after partial ligation of single extrahepatic vascular anomalies in 20 dogs. Vet Surg. 1995;24:379. doi: 10.1111/j.1532-950x.1995.tb01347.x. [DOI] [PubMed] [Google Scholar]
  33. Lamb CR, White RN. Morphology of congenital intra-hepatic portacaval shunts in dogs and cats. Vet Rec. 1998;142:55. doi: 10.1136/vr.142.3.55. [DOI] [PubMed] [Google Scholar]
  34. Lowseth LA. Detection of serum alpha-fetoprotein in dogs with hepatic tumors. J Am Vet Med Assoc. 1991;199:735. [PubMed] [Google Scholar]
  35. MacPhail CM. Hepatocellular toxicosis associated with administration of carprofen in 21 dogs. J Am Vet Med Assoc. 1998;212:1895. [PubMed] [Google Scholar]
  36. Magne ML, Withrow SJ. Hepatic neoplasia. Vet Clin North Am. 1985;15:243. doi: 10.1016/s0195-5616(85)50014-5. [DOI] [PubMed] [Google Scholar]
  37. Neer TM. A review of disorders of the gallbladder and extrahepatic biliary tract in the dog and cat. J Vet Intern Med. 1992;6:186. doi: 10.1111/j.1939-1676.1992.tb00335.x. [DOI] [PubMed] [Google Scholar]
  38. Nyland TG, Gillett NA. Sonographic evaluation of experimental bile duct ligation in the dog. Vet Radiol Ultrasound. 1982;23:252. [Google Scholar]
  39. Nyland TG, Hager DA. Sonography of the liver, gallbladder, and spleen. Vet Clin North Am. 1985;15:1123. doi: 10.1016/s0195-5616(85)50361-7. [DOI] [PubMed] [Google Scholar]
  40. Schermerhorn T. Characterization of hepatoportal microvascular dysplasia in a kindred of cairn terriers. J Vet Intern Med. 1996;10:219. doi: 10.1111/j.1939-1676.1996.tb02053.x. [DOI] [PubMed] [Google Scholar]
  41. Strombeck DR. Small animal gastroenterology. Stonegate Publishing; Davis, Calif: 1979. [Google Scholar]
  42. Strombeck DR, Miller LM, Harrold D. Effects of corticosteroid treatment on survival time in dogs with chronic hepatitis: 151 cases (1977–1985) J Am Vet Med Assoc. 1988;193:1109. [PubMed] [Google Scholar]
  43. Strombeck DR, Schaeffer MC, Rogers QR. Dietary therapy for dogs with chronic hepatic insufficiency. In: Kirk RW, editor. Current veterinary therapy VIII. WB Saunders; Philadelphia: 1983. [Google Scholar]
  44. Taboada J, Meyer DJ. Cholestasis associated with extra-hepatic bacterial infection in five dogs. J Vet Intern Med. 1989;3:216. doi: 10.1111/j.1939-1676.1989.tb00860.x. [DOI] [PubMed] [Google Scholar]
  45. Tams TR. Hepatic encephalopathy. Vet Clin North Am. 1985;15:177. doi: 10.1016/s0195-5616(85)50010-8. [DOI] [PubMed] [Google Scholar]
  46. Thornburg LP. Hepatic copper concentrations in purebred and mixed-breed dogs. Vet Pathol. 1990;27:81. doi: 10.1177/030098589002700202. [DOI] [PubMed] [Google Scholar]
  47. Twedt DC, Hunsaker HA, Allen KGD. Use of 2,3,2-tetramine as a hepatic copper chelating agent for treatment of copper hepatotoxicosis in Bedlington terriers. J Am Vet Med Assoc. 1988;192:52. [PubMed] [Google Scholar]
  48. Vogt JC. Gradual occlusion of extrahepatic portosystemic shunts in dogs and cats using the ameroid constrictor. Vet Surg. 1996;25:495. doi: 10.1111/j.1532-950x.1996.tb01449.x. [DOI] [PubMed] [Google Scholar]
  49. White RN. A method for controlling portal pressure after attenuation of intrahepatic portacaval shunts. Vet Surg. 1996;25:407. doi: 10.1111/j.1532-950x.1996.tb01436.x. [DOI] [PubMed] [Google Scholar]
  50. Wilson SM, Feldman EC. Diagnostic value of the steroid-induced isoenzyme of alkaline phosphatase in the dog. J Am Anim Hosp Assoc. 1992;28:245. [Google Scholar]
  51. Yeager AE, Mohammed H. Accuracy of ultrasonography in the detection of severe hepatic lipidosis in cats. Am J Vet Res. 1992;53:597. [PubMed] [Google Scholar]
  52. Youmans KR, Hunt GB. Experimental evaluation of four methods of progressive venous attenuation in dogs. Vet Surg. 1999;28:38. doi: 10.1053/jvet.1999.0038. [DOI] [PubMed] [Google Scholar]

Articles from Handbook of Small Animal Gastroenterology are provided here courtesy of Elsevier

RESOURCES